Description of original award (Fiscal Year 2020, $1,865,325)
The Harold Rogers Prescription Drug Monitoring Program (PDMP) enhances the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data and other scheduled chemical products through a centralized database administered by an authorized agency.
PDMPs help state and local governments to detect and prevent the diversion and abuse of pharmaceutically controlled substances such as opioids and other prescription drugs. The Harold Rogers PDMP strengthens states and territories ability to plan, implement, or enhance PDMPs by accommodating local decision-making based on state laws and preferences, while encouraging the replication of promising practices. In addition to supporting the implementation and enhancement of PDMPs, the program can support the Administrations priority of tracking prescribing across providers and states through the integration of PDMPs and Electronic Health Records (EHRs) and Health Information Exchanges (HIEs) which are essential to promoting safe and responsible prescribing, while also assuring appropriate pain care.
The applicant will take the necessary steps to add gabapentin as a reportable drug in the PDMP system, evaluate the use of gabapentin in the state to establish a baseline, review gabapentin dispensing data for potential misuse and abuse, review gabapentin dispensing data combined with data from accidental overdose at the for the potential change in schedule, continue to focus on increasing registration and usage of the system for law enforcement, enhance the current enforcement activities of the PMP, and enhance investigations of noncompliance with the PDMP review mandates.